Jean Gauthier

1.1k total citations
31 papers, 728 citations indexed

About

Jean Gauthier is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jean Gauthier has authored 31 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Jean Gauthier's work include HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (4 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Jean Gauthier is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (4 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Jean Gauthier collaborates with scholars based in Canada, France and Egypt. Jean Gauthier's co-authors include Pierre L. Beaulieu, George Kukolj, Ginette McKercher, Fred Saad, Anne‐Marie Mes‐Masson, Sylvie Goulet, Jean‐Simon Duceppe, Marc‐André Poupart, Yves Bousquet and James Gillard and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jean Gauthier

31 papers receiving 697 citations

Peers

Jean Gauthier

HEPAT

EPIDE

Gulrez Fazal Canada

Anke Krüger Germany

Peter W. White Canada

Junxing Shi United States

Chung-Chi Lee Taiwan

Blanda Stammen United Kingdom

Xiu Yu United States

Ginette McKercher Canada

Vincent Lévêque United States

Laval Chan Canada

Gulrez Fazal Canada

Jean Gauthier

371 ×1.5

HEPAT

275 ×1.3

EPIDE

207 ×1.0

256 ×1.3

267 ×1.4

Citations per year, relative to Jean Gauthier Jean Gauthier (= 1×) peers Gulrez Fazal

Countries citing papers authored by Jean Gauthier

Since Specialization

Citations

This map shows the geographic impact of Jean Gauthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Gauthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Gauthier more than expected).

Fields of papers citing papers by Jean Gauthier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Gauthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Gauthier. The network helps show where Jean Gauthier may publish in the future.

Co-authorship network of co-authors of Jean Gauthier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Gauthier. A scholar is included among the top collaborators of Jean Gauthier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Gauthier. Jean Gauthier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubois, Clémence, Corinne Aubel, Jean Gauthier, et al.. (2021). LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models. Cancers. 13(16). 4050–4050. 8 indexed citations

Pezel, Théo, Emmanuelle Berthelot, Jean Gauthier, et al.. (2020). Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study). Archives of cardiovascular diseases. 114(1). 51–58. 12 indexed citations

Abisror, Noémie, A. Mékinian, Véronique Le Guern, et al.. (2018). FRI0508 Analysis of risk factors of adverse obstetrical outcome in patients with takayasu arteritis. Annals of the Rheumatic Diseases. 77. 781–782. 1 indexed citations

Gauthier, Jean. (2006). [The heart and doping].. PubMed. 99(11). 1126–9. 2 indexed citations

Kukolj, George, Graham A. McGibbon, Ginette McKercher, et al.. (2005). Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 280(47). 39260–39267. 100 indexed citations

Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. Bioorganic & Medicinal Chemistry Letters. 14(4). 967–971. 74 indexed citations

Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2003). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 119–124. 82 indexed citations

Gauthier, Jean. (2002). [Blood doping and cardiovascular consequences].. PubMed. 31(40). 1904–8. 2 indexed citations

Llinàs‐Brunet, Montse, Dale R. Cameron, Jean‐Marie Ferland, et al.. (1999). Phosphotyrosine-Containing Dipeptides as High-Affinity Ligands for the p56^lck SH2 Domain. Journal of Medicinal Chemistry. 42(4). 722–729. 10 indexed citations

10.

Gauthier, Jean. (1999). Writing to families. Psychiatric Bulletin. 23(7). 387–389. 2 indexed citations

11.

Mes‐Masson, Anne‐Marie, et al.. (1998). Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer. Molecular Carcinogenesis. 21(3). 164–170. 6 indexed citations

12.

Mes‐Masson, Anne‐Marie, et al.. (1998). Analysis of thep16 tumor suppressor gene in early-stage prostate cancer. Molecular Carcinogenesis. 21(3). 164–170. 34 indexed citations

13.

Duan, Jianmin, Michel Liuzzi, Michelle Lambert, et al.. (1998). Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo. Antimicrobial Agents and Chemotherapy. 42(7). 1629–1635. 35 indexed citations

14.

Mes‐Masson, Anne‐Marie, et al.. (1996). Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Cancer Letters. 99(2). 185–189. 56 indexed citations

15.

Searle, Norman R., et al.. (1995). An evaluation of the N-CAT, a new arterial tonometer. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 42(6). 526–531. 3 indexed citations

16.

Moss, Neil, Pierre L. Beaulieu, Jean‐Simon Duceppe, et al.. (1995). Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents. Journal of Medicinal Chemistry. 38(18). 3617–3623. 26 indexed citations

17.

Ricco, Jean‐Baptiste, et al.. (1991). Remote Arteriovenous Fistula with Infrapopliteal Polytetrafluoroethylene Bypass for Critical Ischemia. Annals of Vascular Surgery. 5(6). 525–528. 4 indexed citations

18.

Fazal, Gulrez, et al.. (1991). A new solid phase strategy for the synthesis of mammalian glucagon. Tetrahedron Letters. 32(5). 577–580. 5 indexed citations

19.

Ferland, Jean‐Marie, et al.. (1989). Photolabile p-methoxyphenacyloxycarbonyl group for the protection of amines. Tetrahedron Letters. 30(15). 1901–1904. 11 indexed citations

20.

Duceppe, Jean‐Simon & Jean Gauthier. (1984). Synthesis of 5H‐imidazo[2,1‐c]pyrrolo[1,2‐a][1,4]benzodiazepine. Journal of Heterocyclic Chemistry. 21(6). 1685–1687. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact